跳至主要内容
临床试验/JPRN-UMIN000021457
JPRN-UMIN000021457已完成未知

Hepatic Artery Embolization with Microsphere for Large Hepatocellular Carcinoma - HAMLET study

Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization0 个研究点目标入组 25 人开始时间: 2016年3月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of the surgery or endoscopic treatment of the biliary duct 2) Sever arterioportal shunt or arteriovenous shunt 3) Sever stenosis or occlusion of the hepatic artery 4) History of rupture of hepatocellular carcionma 5) Treatment refractory pleural effusion or ascites 6) Sever complication: heart failure, angina pectoris, arrhythmia myocardial infarction duplicate active cancer active infection active gastrointestinal hemorrhage hepatic encephalopathy, mental disorder iodine allergy, sever drug allergy 7) Pregnant woman or woman who want to be pregnant 8) Qualified ineligible patients being this clinical trial by responsible doctor

研究者

发起方
Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization

相似试验